InsiderClue
Insiders · Profile

Shenouda Maged

Chief Financial Officer at RELMADA THERAPEUTICS · CHIEF FINANCIAL OFFICER at GridAI Technologies. Filing since 14 Dec 2015. CIK 0001658369

RLMD RELMADA THERAPEUTICS, INC. Chief Financial Officer · 30 trades GRDX GridAI Technologies Corp. CHIEF FINANCIAL OFFICER · 1 trade
Company
Date
Role
Action
Shares
Amount
Of holding
RLMD RELMADA THERAPEUTICS, INC.
10 Sep 2026
Chief Financial Officer
Bought
79,800
$339.15K
8.7%
RLMD RELMADA THERAPEUTICS, INC.
9 Sep 2026
Chief Financial Officer
Bought
120,200
$504.84K
15.0%
RLMD RELMADA THERAPEUTICS, INC.
15 Dec 2025
Chief Financial Officer
Bought
11,665
$48.06K
1.5%
RLMD RELMADA THERAPEUTICS, INC.
5 Nov 2025
Chief Financial Officer
Bought
500,000
$1.10M
173%
RLMD RELMADA THERAPEUTICS, INC.
20 May 2025
Chief Financial Officer
Bought
60,000
$31.42K
26.3%
RLMD RELMADA THERAPEUTICS, INC.
19 May 2025
Chief Financial Officer
Bought
90,000
$43.69K
65.1%
RLMD RELMADA THERAPEUTICS, INC.
16 May 2025
Chief Financial Officer
Bought
50,000
$22.10K
56.6%
RLMD RELMADA THERAPEUTICS, INC.
11 Sep 2024
Chief Financial Officer
Bought
24,120
$71.15K
37.6%
RLMD RELMADA THERAPEUTICS, INC.
10 Sep 2024
Chief Financial Officer
Bought
21,118
$57.65K
49.0%
RLMD RELMADA THERAPEUTICS, INC.
9 Sep 2024
Chief Financial Officer
Bought
8,194
$20.89K
23.5%
RLMD RELMADA THERAPEUTICS, INC.
31 Jan 2024
Chief Financial Officer
Bought
6,875
$27.94K
24.5%
RLMD RELMADA THERAPEUTICS, INC.
30 Jan 2024
Chief Financial Officer
Bought
15,000
$58.32K
115%
RLMD RELMADA THERAPEUTICS, INC.
29 Jan 2024
Chief Financial Officer
Bought
10,800
$39.45K
485%
RLMD RELMADA THERAPEUTICS, INC.
10 Mar 2021
CFO
Sold, plan not stated
2,373
$83.31K
51.6%
RLMD RELMADA THERAPEUTICS, INC.
9 Mar 2021
CFO
Sold, plan not stated
7,527
$267.69K
62.1%
RLMD RELMADA THERAPEUTICS, INC.
8 Mar 2021
CFO
Sold, plan not stated
100
$3.50K
0.8%
RLMD RELMADA THERAPEUTICS, INC.
24 Feb 2021
CFO
Sold, plan not stated
3,000
$102.53K
57.4%
RLMD RELMADA THERAPEUTICS, INC.
11 Feb 2021
CFO
Sold, plan not stated
1,428
$50.54K
39.1%
RLMD RELMADA THERAPEUTICS, INC.
10 Feb 2021
CFO
Sold, plan not stated
2,410
$84.83K
52.0%
RLMD RELMADA THERAPEUTICS, INC.
9 Feb 2021
CFO
Sold, plan not stated
5,359
$188.84K
53.6%
RLMD RELMADA THERAPEUTICS, INC.
8 Feb 2021
CFO
Sold, plan not stated
3,603
$126.24K
26.5%
RLMD RELMADA THERAPEUTICS, INC.
3 Feb 2021
CFO
Sold, plan not stated
100
$3.50K
4.3%
RLMD RELMADA THERAPEUTICS, INC.
2 Feb 2021
CFO
Sold, plan not stated
3,100
$108.63K
57.1%
RLMD RELMADA THERAPEUTICS, INC.
27 Jan 2021
CFO
Sold, plan not stated
3,000
$95.78K
57.4%
RLMD RELMADA THERAPEUTICS, INC.
26 Jan 2021
CFO
Sold, plan not stated
607
$21.34K
21.4%
RLMD RELMADA THERAPEUTICS, INC.
25 Jan 2021
CFO
Sold, plan not stated
1,280
$45.15K
31.1%
RLMD RELMADA THERAPEUTICS, INC.
22 Jan 2021
CFO
Sold, plan not stated
2,113
$75.12K
33.9%
RLMD RELMADA THERAPEUTICS, INC.
21 Oct 2019
Director
Bought
978
$22.49K
78.2%
GRDX GridAI Technologies Corp.
28 Dec 2018
CHIEF FINANCIAL OFFICER
Bought
20,000
$26.21K
47.1%
RLMD RELMADA THERAPEUTICS, INC.
15 Dec 2015
Director
Bought
3,000
$8.96K
150%
RLMD RELMADA THERAPEUTICS, INC.
14 Dec 2015
Director
Bought
2,000
$5.78K
opened
31 decisions on file.